相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kinome expression profiling to target new therapeutic avenues in multiple myeloma
Hugues de Boussac et al.
HAEMATOLOGICA (2020)
PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma
Chengyuan Dong et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma
Hideo Takahashi et al.
CANCERS (2020)
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Yu-Chin Liu et al.
CELLS (2020)
Nanotheranostics: Their role in hepatocellular carcinoma
Rama Rao Malla et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway
Qiu-Xia Yang et al.
CANCER LETTERS (2019)
Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
Juanjuan Xiao et al.
CELL DEATH & DISEASE (2019)
Analysis of MAPK and MAPKK gene families in wheat and related Triticeae species
Ravinder K. Goyal et al.
BMC GENOMICS (2018)
PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia
Jingliao Zhang et al.
CELLULAR SIGNALLING (2018)
MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy
Wei-Wei Ren et al.
CELL DEATH & DISEASE (2018)
Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays
Tzu-Cheng Su et al.
PLOS ONE (2018)
Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
Fang Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics
Katharine J. Herbert et al.
CELL DEATH & DISEASE (2018)
Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature
Jian-Chun Lu et al.
WORLD JOURNAL OF CLINICAL CASES (2018)
Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
Issei Saeki et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase
Jun Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis
Chae Hwa Kwon et al.
ONCOTARGET (2016)
The Protective Role of the TOPK/PBK Pathway in Myocardial Ischemia/Reperfusion and H2O2-Induced Injury in H9C2 Cardiomyocytes
Guozhe Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
Chin-Fang Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
Xiaoyan Dou et al.
CANCER CELL INTERNATIONAL (2015)
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
Mrinal Joel et al.
MOLECULAR CANCER (2015)
Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC
Kun Ding et al.
ONCOLOGY REPORTS (2015)
PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion
Joshua D. Brown-Clay et al.
ONCOTARGET (2015)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer
M-C Shih et al.
ONCOGENE (2012)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21
F. Hu et al.
ONCOGENE (2010)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
A mitotic kinase TOPK enhances cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis
Yasuhito Abe et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase
JD Dougherty et al.
JOURNAL OF NEUROSCIENCE (2005)
Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents
T Endo et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells
Y Abe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
